Although reduced FHactivity was observed in MS-MSC, this effect did not reach statistical significanceafter adjustment for differences in age between the cohorts and furthermore, nodifference was seen when FH activity was assessed in mitochondrial preparations fromMSC isolated from control subjects and people with progressive MS. Here, FH is linked to myeloid sarcoma.